Targeting Mutations in Myeloma with Venetoclax and Development of the First MM Platform Trial - MyDRUG
By
Indy Hematology Review
FEATURING
Kenneth Anderson
By
Indy Hematology Review
FEATURING
Kenneth Anderson
Login to view comments.
Click here to Login